StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)

Close on Nov 17, 2026Market cap $156.11MP/E –Yield –

NervGen Pharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

NervGen Pharma's enterprise value was $91.88M on Nov 11, 2026, against $288.67M a year earlier. Over the last 3 years it ranged from $76.69M to $381.27M, with a median of $136.60M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$91.88M-75.9%
2025Dec 31, 2025$381.27M+212.9%
2024Dec 31, 2024$121.85M–

More NervGen Pharma figures

See a number that looks wrong?